A novel locus for autosomal-dominant dilated cardiomyopathy maps to chromosome 7q22.3-31.1

Jost Schönberger1, Leif Kühler, Elisabete Martins

  • 1Department of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Grombühlstr. 12, 97080, Würzburg, Germany.

Human Genetics
|October 18, 2005
PubMed

Insights

Researchers identified a novel genetic locus for inherited dilated cardiomyopathy (DCM) on chromosome 7q22.3-31.1 in a large family. This finding advances understanding of DCM

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Inherited dilated cardiomyopathy (DCM) presents significant genetic and phenotypic heterogeneity.
  • Its complex pathophysiology involves numerous genes affecting cardiac function, energy production, and signaling pathways.
  • Familial DCM studies are crucial for discovering novel genes and understanding cardiac disease mechanisms.

Purpose of the Study:

  • To identify the genetic cause of dilated cardiomyopathy in a three-generation family.
  • To investigate the genetic basis of DCM inheritance and penetrance.

Main Methods:

  • Genome-wide linkage analysis was performed on a 16-member family affected by DCM.
  • Genetic markers on chromosome 7q22.3-31.1 were analyzed for segregation with the disease.
  • Candidate genes within the linked interval were screened for mutations.

Main Results:

  • A novel locus for autosomal-dominant DCM was mapped to chromosome 7q22.3-31.1, excluding known DCM genes.
  • Linkage analysis yielded a maximum logarithm of odds score of 4.20.
  • The disease-causing mutation is located in a 9.73 Mb interval between D7S2545 and D7S2554, containing no known cytoskeletal genes.

Conclusions:

  • A new genetic locus on chromosome 7q22.3-31.1 is associated with inherited dilated cardiomyopathy.
  • This discovery provides a new target for understanding DCM pathogenesis.
  • Further investigation is needed to identify the specific mutation within the identified interval.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Pedigree Analysis01:35

Pedigree Analysis

Overview